TREATMENT OF GENITAL AND LABIAL HERPES
This article summarizes the study of a total of 146 patients under observation, there were 63 men, 83 women. -50 years -23, over 50 years 4. According to the PCR study, HSV-1 was detected in 30 (20.5%) patients, HSV-2 in 49 (33.5%), HSV1 + HSV2 in 23 (15.8%), HSV without type identification in 18 (12.3%), a negative result was obtained in 6 (4.1%), no study was conducted, in 20 (13.8%) patients. Genital herpes was in 115 patients, labial herpes in 31 patients. The duration of the disease from 1 to 5 years was noted in 49% of patients, 6-10 years in 26%, 10-15 years in 14%, 16-18 years in 11% of patients. The objective of our work was to evaluate the clinical efficacy, tolerability and safety of Kagocel® in the treatment of genital and labial herpes .
Сведения
- Опубликовано
- 2022 · Т. 2, № 10
- Источник
- cyberleninka.ru
- Язык
- Английский
- Издатель
- Central Asian Research Journal (CARJIS) ALFRAGANUS universiteti, Бухоро давлат тиббиёт институти